Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Zhejiang Huahai Pharmaceutical Co, Ltd. (600521 CH)
Watchlist
26
Analysis
Health Care
•
China
Zhejiang Huahai Pharmaceutical Co., Ltd. manufactures and retails pharmaceutical products and medical raw materials. The Company exports its products to many parts of the world.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Ovctek China
•
28 May 2023 09:22
China Healthcare Weekly (May.26)- 9th National VBP, China's Strength in ADC Field, Ovctek, Eyebright
The 9th national VBP is coming, but policy could change from 2026.We see positive factors in the performance of Chinese company in ADC field, who...
Xinyao (Criss) Wang
Follow
359 Views
Share
bullish
•
Cross Asset Strategy
•
23 Aug 2022 09:52
•
Syndicated
CX Daily: Sichuan Power Crunch Sparks Calls for Rethink of Coal in China’s Energy Mix
Cover Story: Sichuan power crunch sparks calls for rethink of coal in China’s energy mix. Suspects arrested as Hong Kong police crack down on cross...
Caixin Global
Follow
170 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 Jun 2022 09:19
Geopolitical Conflicts and War: The Impact on China API Industry
Energy/food crisis due to war will increase API cost, creating opportunity for China API. For IPEF/Blinken’s speech, politics is always a tool to...
Xinyao (Criss) Wang
Follow
230 Views
Share
bullish
•
Cross Asset Strategy
•
18 Mar 2022 09:33
•
Syndicated
CX Daily: China’s Tightening of Online Insurance Sales Starts to Bite
In Depth: China’s tightening of online insurance sales starts to bite. Chinese regions offer rewards for tip-offs on trafficked women and children
Caixin Global
Follow
304 Views
Share
bullish
•
Biocytogen Pharmaceuticals (Beijing)
•
16 Feb 2022 09:14
Pre-IPO Biocytogen Pharmaceuticals - The Novel Development Model Offset the Pipeline's Shortcomings
We analyzed the unique development strategy of Biocytogen, and also pointed out the concerns on its pipeline. However, its business model is hard...
Xinyao (Criss) Wang
Follow
252 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x